InvestorsObserver
×
News Home

How High Does Wall Street Think GW Pharmaceuticals PLC- ADR (GWPH) Stock Can Go?

Monday, May 04, 2020 11:55 AM | InvestorsObserver Analysts

Mentioned in this article

How High Does Wall Street Think GW Pharmaceuticals PLC- ADR (GWPH) Stock Can Go?

Wall Street is positive on GW Pharmaceuticals PLC- ADR (GWPH). On average, analysts give the stock a Strong Buy rating. The average price target is $183.133, which means analysts expect the stock to add by 80.16% over the next twelve months.

That average ranking earns the stock an Analyst Rating of 79, which is better than 79% of stocks based on data compiled by InvestorsObserver.

Overall Score - 4.9
Wall Street analysts are rating GWPH a Strong Buy today. Find out what this means to you and get the rest of the rankings on GWPH!

Why are Analyst Ratings Important?

You can learn a lot about a company from looking at it’s financial statements and comparing them to other companies. Analysts who cover an industry in depth can add even more to your research though. They typically follow a particular sector or industry very closely. They also pay attention to and ask questions on earnings conference calls and other events where they might learn information that does show up in the numbers.

InvestorsObserver takes the average rating from these analysts, and then percentile ranks those averages. This lets you compare stocks in a much more granular way than just seeing the typical five-tiered rating system used on most of Wall Street.

What's Happening With GW Pharmaceuticals PLC- ADR Stock Today?

GW Pharmaceuticals PLC- ADR (GWPH) stock has risen 2.26% while the S&P 500 is lower by -0.4% as of 11:52 AM on Monday, May 4. GWPH has gained $2.25 from the previous closing price of $99.40 on volume of 125,212 shares. Over the past year the S&P 500 is lower by -3.86% while GWPH is lower by -43.56%. GWPH lost -$0.29 per share the over the last 12 months.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App